Abdelmoujoud Faris

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 8

Top Topics

Rheumatoid Arthritis

Tyrosine Kinase

Molecular Dynamics

Top Venues

Journal of biomolecular structure & dynamics

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Abdelmoujoud Faris, Ibrahim M Ibrahim, Hanine Hadni, Menana Elhallaoui
High-throughput virtual screening of phenylpyrimidine derivatives as selective JAK3 antagonists using computational methods. Journal of biomolecular structure & dynamics (2023)
Abdelmoujoud Faris, Ibrahim M Ibrahim, Radwan Alnajjar, Hanine Hadni, Mashooq Ahmad Bhat, Muhammad Yaseen, Souvik Chakraborty, Nada Alsakhen, Israa M Shamkh, Fazal Mabood, Ahmed M Naglah, Ihsan Ullah, Noha I Ziedan, Menana Elhallaoui
QSAR-driven screening uncovers and designs novel pyrimidine-4,6-diamine derivatives as potent JAK3 inhibitors. Journal of biomolecular structure & dynamics (2023)
Abdelmoujoud Faris, Ibrahim M Ibrahim, Omkulthom Al Kamaly, Asmaa Saleh, Menana Elhallaoui
Computer-Aided Drug Design of Novel Derivatives of 2-Amino-7,9-dihydro-8H-purin-8-one as Potent Pan-Janus JAK3 Inhibitors. Molecules (Basel, Switzerland) 28 (15) (2023)
Abdelmoujoud Faris, Hanine Hadni, Basil A Saleh, Hadjer Khelfaoui, Dalal Harkati, Hassan Ait Ahsaine, Menana Elhallaoui, Gamal A El-Hiti
In silico screening of a series of 1,6-disubstituted 1 H -pyrazolo[3,4- d ]pyrimidines as potential selective inhibitors of the Janus kinase 3. Journal of biomolecular structure & dynamics (2023)
Abdelmoujoud Faris, Radwan Alnajjar, Jingjing Guo, Mohammed H Al Mughram, Adnane Aouidate, Mufarreh Asmari, Menana Elhallaoui
Computational 3D Modeling-Based Identification of Inhibitors Targeting Cysteine Covalent Bond Catalysts for JAK3 and CYP3A4 Enzymes in the Treatment of Rheumatoid Arthritis. Molecules (Basel, Switzerland) 29 (1) (2023)
Abdelmoujoud Faris, Ivana Cacciatore, Ibrahim M Ibrahim, Mohammed H Al Mughram, Hanine Hadni, Hanine Hadni, Menana Elhallaoui
In silico computational drug discovery: a Monte Carlo approach for developing a novel JAK3 inhibitors. Journal of biomolecular structure & dynamics (2023)
Abdelmoujoud Faris, Radwan Alnajjar, Jingjing Guo, Mohammed H Al Mughram, Adnane Aouidate, Mufarreh Asmari, Menana Elhallaoui
Computational 3D Modeling-Based Identification of Inhibitors Targeting Cysteine Covalent Bond Catalysts for JAK3 and CYP3A4 Enzymes in the Treatment of Rheumatoid Arthritis. Molecules (Basel, Switzerland) 29 (1) (2023)
Abdelmoujoud Faris, Hanine Hadni, Ibrahim M Ibrahim, Menana Elhallaoui
In silico discovery of potent and selective Janus kinase 3 (JAK3) inhibitors through 3D-QSAR, covalent docking, ADMET analysis, molecular dynamics simulations, and binding free energy of pyrazolopyrimidine derivatives. Journal of biomolecular structure & dynamics (2023)